Tumor-infiltrating natural killer cell profiling for therapeutic stratification in patients with resectable non-small cell lung cancer
Atsushi Ito, Sung Wook Kang, Hee-Jin Jang, Ji Seon Shim et autres
Abstract Objective Neoadjuvant chemoimmunotherapy has improved outcomes in resectable non-small cell lung cancer (NSCLC), yet its real-world implementation is often challenged by surgical delays, immune-mediated fibrosis, and postoperative complications. Smokers with NSCLC, despite a high risk for surgical morbidity, show enhanced responses …
us, jp (code pays fourni par la source)
0 citations
bioRxiv (Cold Spring Harbor Laboratory)